The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comparison of 12 current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
X. Li
No relevant relationships to disclose
Q. Lin
No relevant relationships to disclose
M. Dong
No relevant relationships to disclose
X. Wu
No relevant relationships to disclose
L. Wei
No relevant relationships to disclose
J. Wen
No relevant relationships to disclose
X. Ma
No relevant relationships to disclose
Z. Chen
No relevant relationships to disclose